Association of Frailty and Delirium in Elderly Hip Fracture Patients

October 30, 2023 updated by: Beijing Tsinghua Chang Gung Hospital

The Association of Preoperative Frailty Index and Incidence of Postoperative Delirium in Elderly Patients With Hip Fracture: a Prospective Cohort Study

Several studies have shown that frailty can be used as a marker for risk of adverse outcomes in elderly patients such as falls, disability, hospitalization, mortality, and can be used to predict patient clinical outcomes. The purpose of this study is to determine whether preoperative frailty can be used as a diagnostic and predictive factor for postoperative delirium in elderly patients with hip fracture.

Study Overview

Status

Recruiting

Detailed Description

Frailty index (FI) is a reliable method to determine the assessment of frailty in elderly patients. Multiple prospective cohort studies have shown that frailty can be used as a marker for risk of adverse outcomes in older adults such as falls, disability, hospitalization, and mortality, and can be used to predict patient clinical outcomes. Whether frailty could be used as a diagnostic and predictive factor for delirium is urgently needed in a large population.

Therefore, this project intends to conduct a prospective cohort study. Patients will be divided into three groups according to frailty index (FI) before surgery, and delirium status will be evaluated by using scales after surgery, so as to explore the diagnostic and predictive value of frailty on POD. Once confirmed, the results of this study will be helpful for the early identification, screening, diagnosis and evaluation of treatment effect of POD. It is of great scientific significance and social benefit to reduce the incidence of POD, improve the prognosis of vulnerable patients and reduce the burden of disease.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100018
        • Recruiting
        • Beijing Tsinghua Changgung Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients over the age of 65 who underwent surgery for hip fractures

Description

Inclusion Criteria:

  • The subjects were patients with hip fracture;
  • Older than 65 years;
  • Patients signed informed consent;
  • American Society of Anesthesiologist (ASA) Rated I- III;
  • The surgery was performed by the same anesthesia and surgical team.

Exclusion Criteria:

  • Patients cannot sign the consent form or refuse to participate;
  • A history of cognitive impairment;
  • Unable to complete the cognitive function test;
  • Mental disorder during initial assessment;
  • Patients suffering from mental illness or substance use disorder;
  • Incomplete or lost data during follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prefrailty group
According to the frailty index(FI) and FI =0.12~0.25
There are clinically common scales for assessing weakness and delirium.
Other Names:
  • CAM scale
  • Nu-DESC sclae
Frailty group
According to the frailty index(FI) and FI≥ 0.25
There are clinically common scales for assessing weakness and delirium.
Other Names:
  • CAM scale
  • Nu-DESC sclae
Nonfrailty group
According to the frailty index(FI) and FI<0.12
There are clinically common scales for assessing weakness and delirium.
Other Names:
  • CAM scale
  • Nu-DESC sclae

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative delirium(POD) in elderly patients with hip fracture
Time Frame: Postoperative 7 days
The percentage of the study population who developed delirium within seven days of surgery,postoperative delirium(POD) is defined according to the CAM criterion
Postoperative 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Death before and 30 days after discharge
Time Frame: 30 days after discharge
Collection of clinical data in the medical record and follow-up update through telephone
30 days after discharge
Duration of delirium
Time Frame: Postoperative 7 days
The time between the first appearance of delirium
Postoperative 7 days
Delirium drug use
Time Frame: Postoperative 7 days
dosage and name of medication prescribed by a neurologist
Postoperative 7 days
Length of hospital stay (HLOS)
Time Frame: Postoperative 30 days
Collection of clinical data in the medical record
Postoperative 30 days
Length of ICU stay
Time Frame: Postoperative 30 days
Collection of clinical data in the medical record
Postoperative 30 days
Hospital cost
Time Frame: Postoperative 30 days
Expenses during hospitalization
Postoperative 30 days
Dindo-Clavien Classification{References:Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2):205-213.}
Time Frame: Postoperative 30 days

Incidence of serious adverse reactions within 30 days after operation (the therapy used to correct a specific complication is the basis of this classification in order to rank a complication in an objective and reproducible manner.

It consists of 7 grades (I, II, IIIa, IIIb, IVa, IVb and V). The introduction of the subclasses a and b allows a contraction of the classification into 5 grades (I, II, III, IV and V) depending on the size of the population observed or the of the focus of a study.

Complications that have the potential for long-lasting disability after patient's discharge are highlighted in the present classification by a suffix ("d" for disability). This suffix indicates that a follow-up is required to comprehensively evaluate the outcome and related long-term quality of life.)

Postoperative 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Huan Zhang, PhD, Beijing Tsinghua Changgeng Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

January 12, 2022

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 18, 2022

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 30, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Frailty index scale

3
Subscribe